Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
Blommaert AG, Dhôtel H, Ducos B, Durieux C, Goudreau N, Bado A, Garbay C, Roques BP.
Blommaert AG, et al. Among authors: goudreau n.
J Med Chem. 1997 Feb 28;40(5):647-58. doi: 10.1021/jm9603072.
J Med Chem. 1997.
PMID: 9057851
New constrained cyclic pseudopeptide cholecystokinin-B (CCK-B) agonists have been designed on the basis of conformational characteristics of the potent and selective CCK-B agonist Boc-Trp-(NMe)Nle-Asp-Phe-NH2 (Ki = 0.8 nM, selectivity ratio CCK-A/CCK-B > 6000) (Goudreau …
New constrained cyclic pseudopeptide cholecystokinin-B (CCK-B) agonists have been designed on the basis of conformational characteristics of …